Raphas

214260KOSDAQMaterialsTrading normally
US$5.31
▼ −US$0.38 (−6.64%)Close · 2026-10-21
Share price
▼ −49.3%over 1y
25/1026/0126/0426/0726/10
$6$8$10

Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.

What the company does

Raphas makes dissolving microneedle patches, tiny needle arrays that deliver active ingredients through the skin without injections, currently used mainly in cosmetic beauty patches.

It supplies these patches to the beauty and skincare market and is developing versions for pharmaceuticals, vaccines, and medical devices. Listed on KOSDAQ, Korea's tech-focused small-cap board, the company's core business today is cosmetic patches, which account for the bulk of its revenue. Its proprietary manufacturing process, called DEN (Droplet Extension), uses room-temperature air-drying rather than heat or moulds, enabling high-volume production of dissolving microneedle patches.

Summary is AI-generated and may contain errors · figures from DART filings

KEY FACTS
Market capUS$47.3M
SectorMaterials
SubsectorChemicals
MarketKOSDAQ
Cap tierSmall-cap
Financials
7Y · FY2019~2025 · USD · all filed years
Revenue
US$23.4MFY2025 · latest
'19'22'25
low US$13.5Mhigh US$23.4M
Operating profit
−US$2.3MFY2025 · loss · latest
'19'22'25
low −US$4.9Mhigh −US$326.9K
● red = loss year
Net income
−US$3.6MFY2025 · loss · latest
'19'22'25
low −US$7Mhigh US$3.6M
● red = loss year
Hover or tap a year for its figure · red dot = loss year · latest FY2025
Why it matters · Context, not a recommendation

The DEN technology is Raphas's own patented process, described in the filing as capable of producing millions of dissolving microneedle patches per month at high yield.

Quick answers

Raphas in five facts

What does Raphas do?

Raphas makes dissolving microneedle patches, tiny needle arrays that deliver active ingredients through the skin without injections, currently used mainly in cosmetic beauty patches.

Where is Raphas listed and in which sector?

Raphas (Korean name: 라파스) trades under KRX code 214260 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Materials sector, Chemicals.

How large is Raphas?

Its market capitalisation was US$47.3M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).

What were Raphas's latest annual revenue and operating profit?

For fiscal year 2025, Raphas reported revenue of US$23.4M, an operating loss of US$2.3M and a net loss of US$3.6M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 13.9% on the previous year.

Where does this data come from?

Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.

Data sources

Data sources and last updated

Filings and financial statements
DART (dart.fss.or.kr), Korea's official corporate-filing system
Prices, market cap, trading status
KRX (Korea Exchange), via FinanceDataReader
Latest annual financials
Fiscal year 2025, data retrieved from DART on 2026-09-17
Share price and market cap
Close of 2026-10-21
Currency
US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
Company data updated
2026-10-21
Company summary
AI-generated from filings; may contain errors. Information only, not investment advice.